In response to Dr Lloyd's decision to commence earlier anti-HCV screening, Professor Cash suggested that the evaluation of second-generation tests might be modified to accommodate the screening programme in Newcastle. Read more about In response to Dr Lloyd's decision to commence earlier anti-HCV screening, Professor Cash suggested that the evaluation of second-generation tests might be modified to accommodate the screening programme in Newcastle.
Dr Boulton wrote to Dr Lloyd stating that Dr Lloyd's decision to start HCV-testing earlier than the other RTCs was "breaking ranks" and "not conducive to the image of a co-ordinated Service". Read more about Dr Boulton wrote to Dr Lloyd stating that Dr Lloyd's decision to start HCV-testing earlier than the other RTCs was "breaking ranks" and "not conducive to the image of a co-ordinated Service".
Professor Cash defined Dr Lloyd's unilateral action to commence anti-HCV screening earlier than other RTCs as both "disgraceful and mischievous". Read more about Professor Cash defined Dr Lloyd's unilateral action to commence anti-HCV screening earlier than other RTCs as both "disgraceful and mischievous".
Dr Lloyd received a letter of objection from Dr Mitchell in respect of awaiting an informed judgment on testing and Dr Lloyd's decision to commence anti-HCV screening in the Northern Region earlier than the rest of the RTCs. Read more about Dr Lloyd received a letter of objection from Dr Mitchell in respect of awaiting an informed judgment on testing and Dr Lloyd's decision to commence anti-HCV screening in the Northern Region earlier than the rest of the RTCs.
Dr Lloyd wrote to all RTC directors informing them that by 1 July all units of blood for transfusion in the Northern Region would be negative for Hepatitis C antibody. He stated that to not test now, when they had the ability to do so, would be indefensible under Product Liability legislation. Read more about Dr Lloyd wrote to all RTC directors informing them that by 1 July all units of blood for transfusion in the Northern Region would be negative for Hepatitis C antibody. He stated that to not test now, when they had the ability to do so, would be indefensible under Product Liability legislation.
Dr Lloyd wrote to Dr Gunson outlining his reasons for commencing anti-HCV testing in the Northern Region earlier than other RTCs in July 1991. He stated the decision to start testing was based on an imperfect test, but a test that was nonetheless available and which detected a group of people who appeared to be positive for the antibody. The comparative study of the Abbott and Ortho kits would not have influenced his decision as to whether or not to start testing. Read more about Dr Lloyd wrote to Dr Gunson outlining his reasons for commencing anti-HCV testing in the Northern Region earlier than other RTCs in July 1991. He stated the decision to start testing was based on an imperfect test, but a test that was nonetheless available and which detected a group of people who appeared to be positive for the antibody. The comparative study of the Abbott and Ortho kits would not have influenced his decision as to whether or not to start testing.
The Advisory Committee on Transfusion Transmitted Diseases was informed that the proposed starting date of 1991 for anti-HCV screening was difficult because it was considered essential to evaluate the new generation Ortho and Abbott tests prior to the commence of routine screening. Read more about The Advisory Committee on Transfusion Transmitted Diseases was informed that the proposed starting date of 1991 for anti-HCV screening was difficult because it was considered essential to evaluate the new generation Ortho and Abbott tests prior to the commence of routine screening.
A letter from Dr Lloyd to Dr Gunson stated that the Northern Region Blood Transfusion Service would be able to start anti-HCV testing from approximately 1 April 1991. Read more about A letter from Dr Lloyd to Dr Gunson stated that the Northern Region Blood Transfusion Service would be able to start anti-HCV testing from approximately 1 April 1991.
A letter from Dr Douglas Lee to Dr Gunson stated that the earliest date to which he could commit the North West to routine anti-HCV testing would be 1 June 1991. Read more about A letter from Dr Douglas Lee to Dr Gunson stated that the earliest date to which he could commit the North West to routine anti-HCV testing would be 1 June 1991.
A memo from Tony Martin to Dr Gunson noted that 1 June 1991 would be an achievable start date to commence anti-HCV screening for the South Thames Blood Transfusion Service. Read more about A memo from Tony Martin to Dr Gunson noted that 1 June 1991 would be an achievable start date to commence anti-HCV screening for the South Thames Blood Transfusion Service.